124 related articles for article (PubMed ID: 23239554)
1. Hemodynamic effects of cholinesterase inhibition in mild Alzheimer's disease.
Chaudhary S; Scouten A; Schwindt G; Janik R; Lee W; Sled JG; Black SE; Stefanovic B
J Magn Reson Imaging; 2013 Jul; 38(1):26-35. PubMed ID: 23239554
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of functional hyperemia to visual stimulation in mild Alzheimer's disease and its sensitivity to cholinesterase inhibition.
Janik R; Thomason LA; Chaudhary S; Dorr A; Scouten A; Schwindt G; Masellis M; Stanisz GJ; Black SE; Stefanovic B
Biochim Biophys Acta; 2016 May; 1862(5):957-65. PubMed ID: 26521151
[TBL] [Abstract][Full Text] [Related]
3. rCBF and cognitive impairment changes assessed by SPECT and ADAS-cog in late-onset Alzheimer's disease after 18 months of treatment with the cholinesterase inhibitors donepezil or galantamine.
Shirayama Y; Takahashi M; Oda Y; Yoshino K; Sato K; Okubo T; Iyo M
Brain Imaging Behav; 2019 Feb; 13(1):75-86. PubMed ID: 29247294
[TBL] [Abstract][Full Text] [Related]
4. Changes in regional cerebral blood flow and functional connectivity in the cholinergic pathway associated with cognitive performance in subjects with mild Alzheimer's disease after 12-week donepezil treatment.
Li W; Antuono PG; Xie C; Chen G; Jones JL; Ward BD; Franczak MB; Goveas JS; Li SJ
Neuroimage; 2012 Apr; 60(2):1083-91. PubMed ID: 22245641
[TBL] [Abstract][Full Text] [Related]
5. Regional cerebral perfusion alterations in patients with mild cognitive impairment and Alzheimer disease using dynamic susceptibility contrast MRI.
Hauser T; Schönknecht P; Thomann PA; Gerigk L; Schröder J; Henze R; Radbruch A; Essig M
Acad Radiol; 2013 Jun; 20(6):705-11. PubMed ID: 23664398
[TBL] [Abstract][Full Text] [Related]
6. Quantitative assessment of cerebral hemodynamic parameters by QUASAR arterial spin labeling in Alzheimer's disease and cognitively normal Elderly adults at 3-tesla.
Mak HK; Chan Q; Zhang Z; Petersen ET; Qiu D; Zhang L; Yau KK; Chu LW; Golay X
J Alzheimers Dis; 2012; 31(1):33-44. PubMed ID: 22504315
[TBL] [Abstract][Full Text] [Related]
7. The Neuropsychological Correlates of Brain Perfusion and Gray Matter Volume in Alzheimer's Disease.
Tai H; Hirano S; Sakurai T; Nakano Y; Ishikawa A; Kojima K; Li H; Shimada H; Kashiwado K; Mukai H; Horikoshi T; Sugiyama A; Uno T; Kuwabara S
J Alzheimers Dis; 2020; 78(4):1639-1652. PubMed ID: 33185599
[TBL] [Abstract][Full Text] [Related]
8. Cholinergic enhancement increases regional cerebral blood flow to the posterior cingulate cortex in mild Alzheimer's disease.
Iizuka T; Kameyama M
Geriatr Gerontol Int; 2017 Jun; 17(6):951-958. PubMed ID: 27215917
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of treatment with donepezil hydrochloride and changes in regional cerebral blood flow in patients with Alzheimer's disease.
Yoshida T; Ha-Kawa S; Yoshimura M; Nobuhara K; Kinoshita T; Sawada S
Ann Nucl Med; 2007 Jul; 21(5):257-65. PubMed ID: 17634843
[TBL] [Abstract][Full Text] [Related]
10. Early-stage differentiation between presenile Alzheimer's disease and frontotemporal dementia using arterial spin labeling MRI.
Steketee RM; Bron EE; Meijboom R; Houston GC; Klein S; Mutsaerts HJ; Mendez Orellana CP; de Jong FJ; van Swieten JC; van der Lugt A; Smits M
Eur Radiol; 2016 Jan; 26(1):244-53. PubMed ID: 26024845
[TBL] [Abstract][Full Text] [Related]
11. Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors.
Nobili F; Koulibaly M; Vitali P; Migneco O; Mariani G; Ebmeier K; Pupi A; Robert PH; Rodriguez G; Darcourt J
J Nucl Med; 2002 Aug; 43(8):983-90. PubMed ID: 12163621
[TBL] [Abstract][Full Text] [Related]
12. Relationships between cognitive impairment on ADAS-cog and regional cerebral blood flow using SPECT in late-onset Alzheimer's disease.
Takahashi M; Oda Y; Okubo T; Shirayama Y
J Neural Transm (Vienna); 2017 Sep; 124(9):1109-1121. PubMed ID: 28509077
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous measurement of arterial transit time, arterial blood volume, and cerebral blood flow using arterial spin-labeling in patients with Alzheimer disease.
Yoshiura T; Hiwatashi A; Yamashita K; Ohyagi Y; Monji A; Takayama Y; Nagao E; Kamano H; Noguchi T; Honda H
AJNR Am J Neuroradiol; 2009 Aug; 30(7):1388-93. PubMed ID: 19342545
[TBL] [Abstract][Full Text] [Related]
14. Effect of rivastigmine on regional cerebral blood flow in Alzheimer's disease.
Cerci SS; Tamam Y; Kaya H; Yildiz M; Arslan S
Adv Ther; 2007; 24(3):611-21. PubMed ID: 17660172
[TBL] [Abstract][Full Text] [Related]
15. Reduced perfusion in normal-appearing white matter in mild to moderate hypertension as revealed by 3D pseudocontinuous arterial spin labeling.
Wang T; Li Y; Guo X; Huang D; Ma L; Wang DJ; Lou X
J Magn Reson Imaging; 2016 Mar; 43(3):635-43. PubMed ID: 26256700
[TBL] [Abstract][Full Text] [Related]
16. 3.0 T MRI arterial spin labeling and magnetic resonance spectroscopy technology in the application of Alzheimer's disease.
Zou JX; Wang MJ; Lei XJ; Chen XG
Exp Gerontol; 2014 Dec; 60():31-6. PubMed ID: 25220149
[TBL] [Abstract][Full Text] [Related]
17. Cerebral perfusional effects of cholinesterase inhibitors in Alzheimer disease.
Ceravolo R; Volterrani D; Tognoni G; Dell'Agnello G; Manca G; Kiferle L; Rossi C; Logi C; Strauss HW; Mariani G; Murri L
Clin Neuropharmacol; 2004; 27(4):166-70. PubMed ID: 15319702
[TBL] [Abstract][Full Text] [Related]
18. Effects of cilostazol on cognition and regional cerebral blood flow in patients with Alzheimer's disease and cerebrovascular disease: a pilot study.
Sakurai H; Hanyu H; Sato T; Kume K; Hirao K; Kanetaka H; Iwamoto T
Geriatr Gerontol Int; 2013 Jan; 13(1):90-7. PubMed ID: 22672107
[TBL] [Abstract][Full Text] [Related]
19. The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim results.
Amenta F; Carotenuto A; Fasanaro AM; Rea R; Traini E
J Neurol Sci; 2012 Nov; 322(1-2):96-101. PubMed ID: 22959283
[TBL] [Abstract][Full Text] [Related]
20. Multivariate and univariate analysis of continuous arterial spin labeling perfusion MRI in Alzheimer's disease.
Asllani I; Habeck C; Scarmeas N; Borogovac A; Brown TR; Stern Y
J Cereb Blood Flow Metab; 2008 Apr; 28(4):725-36. PubMed ID: 17960142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
